Recently Updated
- 07/01/2011
- Map of Misoprostol Approval
- 06/02/2011
- Map of Mifepristone Approval
- 06/01/2011
- List of Mifepristone Approval
- 06/01/2011
- Misoprostol for Treatment of Postpartum Hemorrhage
- 11/26/2010
- Postpartum Hemorrhage Program Brief
Resources by Topic
Abortion
Improving Current Therapies and Exploring New Options in Abortifacient Technology
The supreme court and the partial-birth abortion ban act of 2003
Abortion in the Middle East and North Africa
Abortion and sex determination
Unsafe Abortion and Strategies to Reduce its Impact on Women’s Lives
Self-induction of abortion among women in the United States
Abortion: What is the problem?
The comparative safety of legal induced abortion and childbirth in the United States
Clinical Research
Contraception
Pericoital Oral Contraception with Levonorgestrel: A Systematic Review
Exploration of a new procedure for sterilization
Infant Health
Community-based kangaroo mother care to prevent neonatal and infant mortality
Materials Development
Materials Development Activities Brief
Medical Abortion
Misoprostol for Early Abortion
Annotated Bibliography - Misoprostol for Early Abortion
Medical Abortion in the U.S.: Mifepristone Fact Sheet
Mifepristone medical abortion in Albania
Regimens of misoprostol with mifepristone for early medical abortion
Use of sequential serum hCG and sonography for medical abortion only when indicated
Are two doses of misoprostol after mifepristone for early abortion better than one?
Alternatives to mifepristone for early medical abortion
Mifepristone for late first trimester abortion
Can mifepristone medical abortion be simplified?
Methotrexate compared to misoprostol alone for early medical abortion
Assessment of pregnancy duration among termination of pregnancy clients in South Africa
Medical Abortion Program Brief
Choices for Medical Abortion Introduction in Brazil, Colombia, Mexico and Peru
Supervision for use of mifepristone medical abortion
Integrating medical abortion into safe abortion services in South Africa
Expanding Choice in Abortion Services in Armenia
Two distinct oral routes of misoprostol in mifepristone medical abortion
Sublingual misoprostol after mifepristone
Non-physician clinicians can safely provide first trimester medical abortion
Oral vs. sublingual misoprostol (400 mcg) following 200 mg mifepristone
Increasing women’s choices in medical abortion in Turkey
Knowledge, attitudes, and practice of abortion among women and doctors in Armenia
Acceptability and feasibility of medical abortion in Nepal
Annotated Bibliography - Mifepristone Medical Abortion
Alternatives to Routine Follow-Up for Early Medical Abortion
Home administration of misoprostol for early medical abortion in India
ICMA Third International Conference
Medical abortion: Outcomes in a family medicine setting
Abortion With Self-Administered Misoprostol: A Guide For Women
Alternatives to routine ultrasound for eligibility assessment prior to medical abortion
Buccal vs. sublingual misoprostol after mifepristone for medical abortion
Ultrasound for eligibility assessment for medical abortion
Introduction and provision of medical abortion: A tale of two countries
Medical abortion for adolescents
Comparing two early medical abortion regimens: Mifepristone+misoprostol vs. misoprostol alone
Review of the Literature on Patient Satisfaction with Early Medical Abortion
Mifepristone and Misoprostol Compared With Misoprostol Alone for Second-trimester Abortion
Two doses of buccal misoprostol following mifepristone
Misoprostol
Misoprostol and Teratogenicity: Reviewing the Evidence
Route of Misoprostol Administration
Misoprostol for Women’s Health
Misoprostol for uterine evacuation in induced abortion and pregnancy failure
Misoprostol, Abortion, and the Law
Other
Comparison of serum markers for thrombophilia and autoimmune disease
Policy and Advocacy
Policy and Advocacy Activities Brief
Postpartum Hemorrhage
Postpartum Hemorrhage: A Challenge for Safe Motherhood
Misoprostol for Prevention of Postpartum Hemorrhage
Reference List - Misoprostol for Prevention of Postpartum Hemorrhage
Postpartum Hemorrhage Program Brief
Treatment of postpartum hemorrhage with misoprostol
Prevention of postpartum hemorrhage with misoprostol
Blood Loss After Vaginal Delivery
Misoprostol for the Treatment of Postpartum Hemorrhage: Findings from Clinical Research Trials
Fever after treatment of postpartum hemorrhage
Misoprostol in addition to routine treatment of postpartum hemorrhage in Pakistan
Misoprostol for the Prevention of Postpartum Hemorrhage: Findings from Research in Pakistan
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 1/2
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 2/2
High fever following postpartum administration of sublingual misoprostol
What measured blood loss tells us about postpartum bleeding
Misoprostol as adjunct treatment for treatment of postpartum haemorrhage
Misoprostol for PPH prevention in homebirths in Pakistan
Misoprostol to augment routine active management of the third stage of labor
Misoprostol for Treatment of Postpartum Hemorrhage
Postpartum hemorrhage: Moving from Research to Reality
The Product Problem: Pathways for Making Misoprostol Available for Postpartum Hemorrhage
Misoprostol for postpartum hemorrhage: Moving from evidence to practice
Misoprostol for the prevention and treatment of postpartum hemorrhage
Pre-eclampsia
Treatment approaches for preeclampsia in low-resource settings
Facility and personnel factors influencing magnesium sulfate use for eclampsia and pre-eclampsia
Pregnancy Failure
Sublingual misoprostol vs. MVA for the treatment of incomplete abortion in Egypt
Oral misoprostol as an alternative to surgical management for incomplete abortion in Ghana
Oral Misoprostol for the Management of Incomplete Abortion in Ecuador
Misoprostol for Incomplete Abortion in Guatemala
Pregnancy Failure and Miscarriage
Misoprostol: A New Addition to Post Abortion Care
Reference List - Misoprostol for Incomplete Abortion and Miscarriage